From Guangzhou to Heidelberg（6）

6月3日16:30，仁医医疗三人团队前往海德堡大学附属医院，拜访妇产科主任 Zivanovic教授及其团队。教授的助理早早在会议室等候，为我们准备了咖啡、饮品和甜咸点心，细致周到。Zivanovic 教授与三位年轻的妇科肿瘤专业进修医生一同出席了会谈。在我们简要介绍了仁医医疗的发展背景与合作模式后，Dr. Herrmann与 Dr. Köhler向我们系统介绍了他们团队的妇科肿瘤专科进修项目。该项目聚焦于妇科恶性肿瘤的临床与科研能力培养，仅向已完成妇科专科认证的医生开放申请。项目总周期为四年：前两年进修医生在德国癌症研究中心（DKFZ）从事科研工作，并参与每周一次的妇科肿瘤多学科会诊；后两年则在海德堡大学附属医院的相关临床科室轮转，全面提升妇科恶性肿瘤诊疗能力。Zivanovic教授强调，这是一个高度专业化的培训路径，符合当前医学日益“亚专科化”的发展趋势。Zivanovic教授自2023年起担任海德堡大学附属医院妇产科主任，加入前曾长期在纽约斯隆·凯特林癌症研究所执业。他拥有国际化的临床与科研背景，致力于将先进的肿瘤治疗理念融入德国妇产科的诊疗实践。他所领导的妇科肿瘤中心是德国癌症学会认证的高水平诊疗与研究单位，核心关注卵巢癌、子宫内膜癌、宫颈癌等多种妇科恶性肿瘤的个体化治疗与综合管理，强调精准医疗、创新临床路径与多学科合作。在交流中，Zivanovic 教授高度肯定了仁医医疗的理念。他表示，近年来在国际会议上频频见到中国同道在妇科肿瘤领域的突出贡献，但苦于缺乏合适的渠道，难以实现深入交流。他坦言，自己每天都收到不少来自中国学生、医生和研究人员的联系请求，但由于数量庞大、背景各异，确实难以甄别与统筹，因此看到我们这样的专业机构介入合作推进，让他感到非常安心与期待。他希望今后能借助仁医医疗与中国开展更直接、更深入的合作交流。

At 16:30 of June 3rd, the team of three from Gloryren went to Heidelberg University Hospital to visit Prof. Zivanovic, Director of the Department of Gynecology and Obstetrics, and his team. Ms. Önal, Prof. Zivanovic’s assistant, was waiting in the conference room, kindly preparing coffee, other drinks, and some sweet and savory snacks for us. Prof. Zivanovic attended the meeting with three fellows. After our brief introduction to Gloryren's background and cooperation model, Dr. Herrmann and Dr. Köhler provided a detailed presentation on the structured fellowship program for gynecologic oncology. This program focuses on the training of both clinical and research competencies in gynecologic malignancies and is open exclusively to certified specialist in gynecology. The total duration of the program is four years: in the first two years, fellows engage in research at the German Cancer Research Center (DKFZ) and participate in weekly multidisciplinary gynecologic tumor boards; in the last two years, they rotate in relevant clinical departments at Heidelberg University Hospital to comprehensively enhance their diagnostic and treatment skills for gynecologic malignancies. Prof. Zivanovic emphasized that this is a highly specialized training pathway that aligns with the current trend toward increasing "subspecialization" in medicine. Since 2023, Prof. Zivanovic has served as the Director of Gynecology and Obstetrics at Heidelberg University Hospital. Before joining Heidelberg University Hospital, he practiced for many years at Memorial Sloan Kettering Cancer Center in New York. With extensive international clinical and research experience, Prof. Zivanovic is dedicated to integrating advanced oncology treatment concepts into the practice of gynecology in Germany. The Center for Gynecological Cancer led by him is a high-level treatment and research center, certified by the German Cancer Society       (DKG). It focuses on the individualized treatment and comprehensive management of various gynecologic malignancies such as ovarian cancer, endometrial cancer, and cervical cancer, with a strong emphasis on precision medicine, innovative clinical pathways, and multidisciplinary collaboration. During the meeting, Prof. Zivanovic highly acknowledged with the concept of Gloryren. He shared that in recent years, he has repeatedly noticed remarkable contributions from Chinese colleagues in the field of gynecologic oncology at international conferences, but due to the limited access, he found it difficult to have in-depth exchanges with them. Therefore, with the help of a professional institution like Gloryren, he has gained a strong sense of confidence and now holds high expectations for the collaboration. He hopes to establish more direct and in-depth exchanges with China via Gloryren in the future.